ICN Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICN Pharmaceuticals

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Young who wrote (769)	3/12/1998 12:11:00 AM
From: Robert Florin	Read Replies (1) of 1029

Most undervalued of the medium size pharm companies IMHO. This is one of those stocks which can give you a good long ride. It is amazing that the company is just getting discovered. When others realize the market potential in Eastern Europe, and the potential sales of Ribavarin to the literally millions with Hep C, it will go up further. Does everyone here know that there is a high incidence of cancer of the liver (fatal) in chronic cases of hep c (many of them). Many of the cases of hep c have previously been undiagnosed. Current lab tests can detect antigen's and antibodies (if present). I would not be surprised to see hepatologists recommending active treatment to non symptomatic hep c positive antigen carriers now that there is a 10x more effective treatment than just Interferon alone.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next